What is Fondaparinux Priced At?
The price of fondaparinux varies significantly based on dosage, form, and supplier. For instance, a 2.5 mg/0.5 mL vial can range from approximately $30 to $50. Higher dosages, such as 7.5 mg/0.6 mL, may cost between $60 and $90 per vial. These figures represent cash prices and do not account for insurance coverage or potential discounts [1].
How Does Fondaparinux Compare to Other Blood Thinners?
Fondaparinux is a synthetic pentasaccharide that selectively inhibits Factor Xa, a key enzyme in the coagulation cascade. This mechanism differentiates it from other anticoagulants like warfarin, which affects multiple vitamin K-dependent clotting factors, or direct oral anticoagulants (DOACs) such as rivaroxaban and apixaban, which directly inhibit Factor Xa or thrombin [2]. The choice of anticoagulant often depends on the specific medical condition, patient risk factors, and treatment goals.
When Does Fondaparinux's Patent Protection End?
Drug patent information, including expiry dates, can be complex and subject to various extensions and legal challenges. For specific details on fondaparinux patent expirations and any related legal proceedings, consulting resources like DrugPatentWatch.com is recommended [3].
Who Manufactures and Distributes Fondaparinux?
Fondaparinux is marketed under the brand name Arixtra, and its manufacturing and distribution are handled by various pharmaceutical companies. The availability and pricing can also be influenced by the presence of generic versions and the specific entities that hold marketing authorizations in different regions [2].
What is Fondaparinux Used For?
Fondaparinux is primarily prescribed for the prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients undergoing hip fracture surgery, hip replacement surgery, or knee replacement surgery. It is also used for the treatment of DVT and PE in patients not undergoing major orthopedic surgery [2].
Can Patients Access Fondaparinux Affordably?
Affordability of fondaparinux can be a concern for patients, particularly those without comprehensive insurance coverage. Several factors influence out-of-pocket costs, including pharmacy pricing, the availability of discount programs offered by manufacturers or third parties, and whether a generic alternative is accessible. Patients are advised to discuss cost-saving options with their healthcare providers and pharmacists [1].